English

MusclePharm Corp

EDGAR

MSLP Registration statement (S-1) · filed 2022-06-17

88 filing records in this dataset, filed from 2008-01-14 to 2022-06-17. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.1 million USD

2022 Q1 · USD

Exact inputs and evidence

Revenue: 13101000 USD Source

Operating margin

-18.93%

2022 Q1 · %

Exact inputs and evidence

Operating Income: -2480000 USD Source
Revenue: 13101000 USD Source

Operating cash flow

-3.58 million USD

2022 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3582000 USD Source

Cash and cash equivalents: 500 thousand USD 2022-03-31 Source
Exact value

500000 USD
Long-term debt including current maturities: 22.4 million USD 2022-03-31 Source
Exact value

22407000 USD
Shares outstanding: 33.4 million shares 2022-03-31 Source
Exact value

33386200 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33386200 shares · 2021-03-31· Source
33386200 shares · 2022-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

50 million USD

2021-04-01 – 2022-03-31

Exact inputs and evidence

Revenue: 14908000 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 11971000 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 50042000 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 40000000 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 13101000 USD · 2022-01-01 – 2022-03-31 Source

Net income

-19.3 million USD

2021-04-01 – 2022-03-31

Exact inputs and evidence

Net income: -2251000 USD · 2021-04-01 – 2021-06-30 Source
Net income: -3933000 USD · 2021-07-01 – 2021-09-30 Source
Net income: -12866000 USD · 2021-01-01 – 2021-12-31 Source
Net income: -6090000 USD · 2021-01-01 – 2021-09-30 Source
Net income: -6301000 USD · 2022-01-01 – 2022-03-31 Source

Operating cash flow

-11.7 million USD

2021-04-01 – 2022-03-31

Exact inputs and evidence

Operating cash flow: -899000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: 98000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -2466000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -899000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -8042000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -2466000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -3582000 USD · 2022-01-01 – 2022-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-06-17.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2021-12-31
Operating income: 11 of 11 periods available· newest 2021-12-31
Net income: 11 of 11 periods available· newest 2021-12-31
Operating cash flow: 11 of 11 periods available· newest 2021-12-31
Capital expenditure: 11 of 11 periods available· newest 2021-12-31
Total assets: 11 of 11 periods available· newest 2021-12-31
Total liabilities: 11 of 11 periods available· newest 2021-12-31
Current assets: 11 of 11 periods available· newest 2021-12-31
Current liabilities: 11 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 11 of 11 periods available· newest 2021-12-31
Shares outstanding: 11 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-22.3%

Prior period

USD 64.44 million

2020-01-01 – 2020-12-31
Current period

USD 50.04 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

50042000 − 64440000 = -14398000 USD

64440000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
50042000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Year-over-year change in Revenue: -14398000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 50042000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2123462 Filing: 000149315222017031 Input fundies:Revenue: 64440000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2123985 Filing: 000149315222017031
The citation records this snapshot. The page link may show a newer release later.
Net income
-504%

Prior period

USD 3.19 million

2020-01-01 – 2020-12-31
Current period

−USD 12.87 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-12866000 − 3185000 = -16051000 USD

3185000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-12866000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Year-over-year change in Net income: -16051000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -12866000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2018777 Filing: 000149315222017031 Input fundies:NetIncome: 3185000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2019204 Filing: 000149315222017031
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 7.17 million

Prior period

−USD 868,000

2020-01-01 – 2020-12-31
Current period

−USD 8.04 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-8042000 − -868000 = -7174000 USD

-868000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-8042000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Year-over-year change in Operating cash flow: -7174000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8042000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501374 Filing: 000149315222017031 Input fundies:OperatingCashFlow: -868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501781 Filing: 000149315222017031
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-50%

Prior period

USD 4,000

2020-01-01 – 2020-12-31
Current period

USD 2,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

2000 − 4000 = -2000 USD

4000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
2000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Year-over-year change in Capital expenditure: -2000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1502923 Filing: 000149315222017031 Input fundies:CapitalExpenditure: 4000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1503249 Filing: 000149315222017031
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 50.04 million 100% of revenue
Cost of revenue USD 44.67 million 89% of revenue
Operating expenses USD 14.28 million 29% of revenue
Operating income −USD 8.91 million −18% of revenue
Tax, interest and other Derived USD 3.95 million 7.9% of revenue
Net income −USD 12.87 million −26% of revenue

Cash

Operating cash flow −USD 8.04 million −16% of revenue
Capital expenditure USD 2,000 0% of revenue
Free cash flow Derived −USD 8.04 million −16% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Operating loss: operating costs were 113% of revenue.
2013 Operating loss: operating costs were 113% of revenue.
2014 Operating loss: operating costs were 111% of revenue.
2015 Operating loss: operating costs were 130% of revenue.
2016 Operating loss: operating costs were 107% of revenue.
2017 Operating loss: operating costs were 107% of revenue.
2018 Operating loss: operating costs were 109% of revenue.
2019 Operating loss: operating costs were 119% of revenue.
2020 Net income was higher than operating income, so the split is not drawn.
2021 Operating loss: operating costs were 118% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2012-01-01 – 2012-12-31	67055000	75791000 Derived	-8736000	10217000 Derived	-18953000	-914000 Derived	Source 2012-01-01 – 2012-12-31: 67055000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -8736000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -18953000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 10000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 924000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	110878000	125175000 Derived	-14297000	3421000 Derived	-17718000	-11884000 Derived	Source 2013-01-01 – 2013-12-31: 110878000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -14297000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -17718000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -9973000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 1911000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	177389000	196765000 Derived	-19376000	-5544000 Derived	-13832000	-8241000 Derived	Source 2014-01-01 – 2014-12-31: 177389000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -19376000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -13832000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -4133000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 4108000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	166858000	216805000 Derived	-49947000	1911000 Derived	-51858000	4015000 Derived	Source 2015-01-01 – 2015-12-31: 166858000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -49947000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -51858000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 5492000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1477000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	132499000	141157000 Derived	-8658000	-5181000 Derived	-3477000	-15576000 Derived	Source 2016-01-01 – 2016-12-31: 132499000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -8658000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -3477000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -15068000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 508000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	93586000	100235000 Derived	-6649000	5860000 Derived	-12509000	-5168000 Derived	Source 2017-01-01 – 2017-12-31: 93586000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6649000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -12509000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5131000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 37000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	88113000	95945000 Derived	-7832000	2923000 Derived	-10755000	1849000 Derived	Source 2018-01-01 – 2018-12-31: 88113000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7832000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -10755000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 1981000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 132000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	79667000	94774000 Derived	-15107000	3820000 Derived	-18927000	-6537000 Derived	Source 2019-01-01 – 2019-12-31: 79667000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -15107000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -18927000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -6524000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 13000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	64440000	61838000 Derived	2602000	-583000 Derived	3185000	-872000 Derived	Source 2020-01-01 – 2020-12-31: 64440000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 2602000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 3185000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -868000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 4000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	50042000	58955000 Derived	-8913000	3953000 Derived	-12866000	-8044000 Derived	Source 2021-01-01 – 2021-12-31: 50042000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -8913000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -12866000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -8042000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 2000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 50M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Revenue	67055000	Revenue: 67055000 Open source
20132013-12-31	Revenue	110878000	Revenue: 110878000 Open source
20142014-12-31	Revenue	177389000	Revenue: 177389000 Open source
20152015-12-31	Revenue	166858000	Revenue: 166858000 Open source
20162016-12-31	Revenue	132499000	Revenue: 132499000 Open source
20172017-12-31	Revenue	93586000	Revenue: 93586000 Open source
20182018-12-31	Revenue	88113000	Revenue: 88113000 Open source
20192019-12-31	Revenue	79667000	Revenue: 79667000 Open source
20202020-12-31	Revenue	64440000	Revenue: 64440000 Open source
20212021-12-31	Revenue	50042000	Revenue: 50042000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-22.3% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Year over year	289.6%	Revenue: 67055000 Open source Revenue: 17212636 Open source
20132013-12-31	Year over year	65.4%	Revenue: 110878000 Open source Revenue: 67055000 Open source
20142014-12-31	Year over year	60%	Revenue: 177389000 Open source Revenue: 110878000 Open source
20152015-12-31	Year over year	-5.9%	Revenue: 166858000 Open source Revenue: 177389000 Open source
20162016-12-31	Year over year	-20.6%	Revenue: 132499000 Open source Revenue: 166858000 Open source
20172017-12-31	Year over year	-29.4%	Revenue: 93586000 Open source Revenue: 132499000 Open source
20182018-12-31	Year over year	-5.8%	Revenue: 88113000 Open source Revenue: 93586000 Open source
20192019-12-31	Year over year	-9.6%	Revenue: 79667000 Open source Revenue: 88113000 Open source
20202020-12-31	Year over year	-19.1%	Revenue: 64440000 Open source Revenue: 79667000 Open source
20212021-12-31	Year over year	-22.3%	Revenue: 50042000 Open source Revenue: 64440000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -17.8% 2021

Net margin -25.7% 2021

Free cash flow margin -16.1% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Operating margin	-13%	Operating Income: -8736000 Open source Revenue: 67055000 Open source
20132013-12-31	Operating margin	-12.9%	Operating Income: -14297000 Open source Revenue: 110878000 Open source
20142014-12-31	Operating margin	-10.9%	Operating Income: -19376000 Open source Revenue: 177389000 Open source
20152015-12-31	Operating margin	-29.9%	Operating Income: -49947000 Open source Revenue: 166858000 Open source
20162016-12-31	Operating margin	-6.5%	Operating Income: -8658000 Open source Revenue: 132499000 Open source
20172017-12-31	Operating margin	-7.1%	Operating Income: -6649000 Open source Revenue: 93586000 Open source
20182018-12-31	Operating margin	-8.9%	Operating Income: -7832000 Open source Revenue: 88113000 Open source
20192019-12-31	Operating margin	-19%	Operating Income: -15107000 Open source Revenue: 79667000 Open source
20202020-12-31	Operating margin	4%	Operating Income: 2602000 Open source Revenue: 64440000 Open source
20212021-12-31	Operating margin	-17.8%	Operating Income: -8913000 Open source Revenue: 50042000 Open source
20122012-12-31	Net margin	-28.3%	Net Income: -18953000 Open source Revenue: 67055000 Open source
20132013-12-31	Net margin	-16%	Net Income: -17718000 Open source Revenue: 110878000 Open source
20142014-12-31	Net margin	-7.8%	Net Income: -13832000 Open source Revenue: 177389000 Open source
20152015-12-31	Net margin	-31.1%	Net Income: -51858000 Open source Revenue: 166858000 Open source
20162016-12-31	Net margin	-2.6%	Net Income: -3477000 Open source Revenue: 132499000 Open source
20172017-12-31	Net margin	-13.4%	Net Income: -12509000 Open source Revenue: 93586000 Open source
20182018-12-31	Net margin	-12.2%	Net Income: -10755000 Open source Revenue: 88113000 Open source
20192019-12-31	Net margin	-23.8%	Net Income: -18927000 Open source Revenue: 79667000 Open source
20202020-12-31	Net margin	4.9%	Net Income: 3185000 Open source Revenue: 64440000 Open source
20212021-12-31	Net margin	-25.7%	Net Income: -12866000 Open source Revenue: 50042000 Open source
20122012-12-31	Free cash flow margin	-1.4%	Revenue: 67055000 Open source Operating Cash Flow: 10000 Open source Capital Expenditure: 924000 Open source
20132013-12-31	Free cash flow margin	-10.7%	Revenue: 110878000 Open source Operating Cash Flow: -9973000 Open source Capital Expenditure: 1911000 Open source
20142014-12-31	Free cash flow margin	-4.6%	Revenue: 177389000 Open source Operating Cash Flow: -4133000 Open source Capital Expenditure: 4108000 Open source
20152015-12-31	Free cash flow margin	2.4%	Revenue: 166858000 Open source Operating Cash Flow: 5492000 Open source Capital Expenditure: 1477000 Open source
20162016-12-31	Free cash flow margin	-11.8%	Revenue: 132499000 Open source Operating Cash Flow: -15068000 Open source Capital Expenditure: 508000 Open source
20172017-12-31	Free cash flow margin	-5.5%	Revenue: 93586000 Open source Operating Cash Flow: -5131000 Open source Capital Expenditure: 37000 Open source
20182018-12-31	Free cash flow margin	2.1%	Revenue: 88113000 Open source Operating Cash Flow: 1981000 Open source Capital Expenditure: 132000 Open source
20192019-12-31	Free cash flow margin	-8.2%	Revenue: 79667000 Open source Operating Cash Flow: -6524000 Open source Capital Expenditure: 13000 Open source
20202020-12-31	Free cash flow margin	-1.4%	Revenue: 64440000 Open source Operating Cash Flow: -868000 Open source Capital Expenditure: 4000 Open source
20212021-12-31	Free cash flow margin	-16.1%	Revenue: 50042000 Open source Operating Cash Flow: -8042000 Open source Capital Expenditure: 2000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -8M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Operating cash flow	10000	Operating Cash Flow: 10000 Open source
20132013-12-31	Operating cash flow	-9973000	Operating Cash Flow: -9973000 Open source
20142014-12-31	Operating cash flow	-4133000	Operating Cash Flow: -4133000 Open source
20152015-12-31	Operating cash flow	5492000	Operating Cash Flow: 5492000 Open source
20162016-12-31	Operating cash flow	-15068000	Operating Cash Flow: -15068000 Open source
20172017-12-31	Operating cash flow	-5131000	Operating Cash Flow: -5131000 Open source
20182018-12-31	Operating cash flow	1981000	Operating Cash Flow: 1981000 Open source
20192019-12-31	Operating cash flow	-6524000	Operating Cash Flow: -6524000 Open source
20202020-12-31	Operating cash flow	-868000	Operating Cash Flow: -868000 Open source
20212021-12-31	Operating cash flow	-8042000	Operating Cash Flow: -8042000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Free cash flow	-914000	Operating Cash Flow: 10000 Open source Capital Expenditure: 924000 Open source
20132013-12-31	Free cash flow	-11884000	Operating Cash Flow: -9973000 Open source Capital Expenditure: 1911000 Open source
20142014-12-31	Free cash flow	-8241000	Operating Cash Flow: -4133000 Open source Capital Expenditure: 4108000 Open source
20152015-12-31	Free cash flow	4015000	Operating Cash Flow: 5492000 Open source Capital Expenditure: 1477000 Open source
20162016-12-31	Free cash flow	-15576000	Operating Cash Flow: -15068000 Open source Capital Expenditure: 508000 Open source
20172017-12-31	Free cash flow	-5168000	Operating Cash Flow: -5131000 Open source Capital Expenditure: 37000 Open source
20182018-12-31	Free cash flow	1849000	Operating Cash Flow: 1981000 Open source Capital Expenditure: 132000 Open source
20192019-12-31	Free cash flow	-6537000	Operating Cash Flow: -6524000 Open source Capital Expenditure: 13000 Open source
20202020-12-31	Free cash flow	-872000	Operating Cash Flow: -868000 Open source Capital Expenditure: 4000 Open source
20212021-12-31	Free cash flow	-8044000	Operating Cash Flow: -8042000 Open source Capital Expenditure: 2000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

400% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Liabilities / assets	244.2%	Total Liabilities: 16524979 Open source Total Assets: 6766727 Open source
20132013-12-31	Liabilities / assets	62.2%	Total Liabilities: 32423000 Open source Total Assets: 52158000 Open source
20142014-12-31	Liabilities / assets	64.8%	Total Liabilities: 42976000 Open source Total Assets: 66356000 Open source
20152015-12-31	Liabilities / assets	115.8%	Total Liabilities: 73849000 Open source Total Assets: 63781000 Open source
20162016-12-31	Liabilities / assets	114.3%	Total Liabilities: 38976000 Open source Total Assets: 34096000 Open source
20172017-12-31	Liabilities / assets	155.5%	Total Liabilities: 47190000 Open source Total Assets: 30342000 Open source
20182018-12-31	Liabilities / assets	214.6%	Total Liabilities: 52796000 Open source Total Assets: 24601000 Open source
20192019-12-31	Liabilities / assets	292.2%	Total Liabilities: 42492000 Open source Total Assets: 14540000 Open source
20202020-12-31	Liabilities / assets	287.8%	Total Liabilities: 37421000 Open source Total Assets: 13002000 Open source
20212021-12-31	Liabilities / assets	400%	Total Liabilities: 42921000 Open source Total Assets: 10730000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.26× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Current assets / current liabilities	0.3×	Current Assets: 4949881 Open source Current Liabilities: 16520456 Open source
20132013-12-31	Current assets / current liabilities	1.38×	Current Assets: 44527000 Open source Current Liabilities: 32369000 Open source
20142014-12-31	Current assets / current liabilities	1.08×	Current Assets: 46417000 Open source Current Liabilities: 42830000 Open source
20152015-12-31	Current assets / current liabilities	0.7×	Current Assets: 47279000 Open source Current Liabilities: 67288000 Open source
20162016-12-31	Current assets / current liabilities	0.75×	Current Assets: 28794000 Open source Current Liabilities: 38436000 Open source
20172017-12-31	Current assets / current liabilities	0.99×	Current Assets: 27890000 Open source Current Liabilities: 28101000 Open source
20182018-12-31	Current assets / current liabilities	0.43×	Current Assets: 22827000 Open source Current Liabilities: 52558000 Open source
20192019-12-31	Current assets / current liabilities	0.29×	Current Assets: 12163000 Open source Current Liabilities: 41541000 Open source
20202020-12-31	Current assets / current liabilities	0.37×	Current Assets: 11864000 Open source Current Liabilities: 32007000 Open source
20212021-12-31	Current assets / current liabilities	0.26×	Current Assets: 10487000 Open source Current Liabilities: 40595000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	−USD 18.95 million Exact value Exact value: -18953000 USD 2012-01-01 – 2012-12-31: -18953000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2012-12-31 MusclePharm Corp (edgar:1415684) Net Income: -18953000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18953000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000156459015001728/mslp-20141231.xml#165251 Filing: 000156459015001728 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2012-01-01 – 2012-12-31: 10000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2012-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: 10000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000156459015001728/mslp-20141231.xml#213372 Filing: 000156459015001728 The citation records this snapshot. The page link may show a newer release later.	USD 924,000 Exact value Exact value: 924000 USD 2012-01-01 – 2012-12-31: 924000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2012-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 924000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 924000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000156459015001728/mslp-20141231.xml#214687 Filing: 000156459015001728 The citation records this snapshot. The page link may show a newer release later.	−USD 914,000 Calculation and evidence 10000 − 924000 USD Exact free cash flow: -914000 USD 2012-01-01 – 2012-12-31: 10000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 924000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2012-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -914000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000156459015001728/mslp-20141231.xml#213372 Filing: 000156459015001728 Input fundies:CapitalExpenditure: 924000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000156459015001728/mslp-20141231.xml#214687 Filing: 000156459015001728 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 17.72 million Exact value Exact value: -17718000 USD 2013-01-01 – 2013-12-31: -17718000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2013-12-31 MusclePharm Corp (edgar:1415684) Net Income: -17718000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17718000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#131033 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	−USD 9.97 million Exact value Exact value: -9973000 USD 2013-01-01 – 2013-12-31: -9973000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2013-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -9973000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9973000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#128521 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	USD 1.91 million Exact value Exact value: 1911000 USD 2013-01-01 – 2013-12-31: 1911000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2013-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 1911000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1911000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#130257 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	−USD 11.88 million Calculation and evidence -9973000 − 1911000 USD Exact free cash flow: -11884000 USD 2013-01-01 – 2013-12-31: -9973000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1911000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2013-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -11884000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9973000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#128521 Filing: 000119312516507417 Input fundies:CapitalExpenditure: 1911000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#130257 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 13.83 million Exact value Exact value: -13832000 USD 2014-01-01 – 2014-12-31: -13832000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2014-12-31 MusclePharm Corp (edgar:1415684) Net Income: -13832000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13832000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#188242 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	−USD 4.13 million Exact value Exact value: -4133000 USD 2014-01-01 – 2014-12-31: -4133000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2014-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -4133000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4133000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#185717 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	USD 4.11 million Exact value Exact value: 4108000 USD 2014-01-01 – 2014-12-31: 4108000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2014-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 4108000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4108000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#187722 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.	−USD 8.24 million Calculation and evidence -4133000 − 4108000 USD Exact free cash flow: -8241000 USD 2014-01-01 – 2014-12-31: -4133000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 4108000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2014-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -8241000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4133000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#185717 Filing: 000119312516507417 Input fundies:CapitalExpenditure: 4108000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000119312516507417/mslp-20151231.xml#187722 Filing: 000119312516507417 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 51.86 million Exact value Exact value: -51858000 USD 2015-01-01 – 2015-12-31: -51858000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2015-12-31 MusclePharm Corp (edgar:1415684) Net Income: -51858000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51858000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000141568417000012/mslp-20161231.xml#190352 Filing: 000141568417000012 The citation records this snapshot. The page link may show a newer release later.	USD 5.49 million Exact value Exact value: 5492000 USD 2015-01-01 – 2015-12-31: 5492000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2015-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: 5492000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5492000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000141568417000012/mslp-20161231.xml#198812 Filing: 000141568417000012 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1477000 USD 2015-01-01 – 2015-12-31: 1477000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2015-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 1477000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1477000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000141568417000012/mslp-20161231.xml#199297 Filing: 000141568417000012 The citation records this snapshot. The page link may show a newer release later.	USD 4.02 million Calculation and evidence 5492000 − 1477000 USD Exact free cash flow: 4015000 USD 2015-01-01 – 2015-12-31: 5492000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1477000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2015-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: 4015000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5492000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000141568417000012/mslp-20161231.xml#198812 Filing: 000141568417000012 Input fundies:CapitalExpenditure: 1477000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000141568417000012/mslp-20161231.xml#199297 Filing: 000141568417000012 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 3.48 million Exact value Exact value: -3477000 USD 2016-01-01 – 2016-12-31: -3477000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2016-12-31 MusclePharm Corp (edgar:1415684) Net Income: -3477000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3477000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495418003486/mslp-20171231.xml#97676 Filing: 000165495418003486 The citation records this snapshot. The page link may show a newer release later.	−USD 15.07 million Exact value Exact value: -15068000 USD 2016-01-01 – 2016-12-31: -15068000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2016-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -15068000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15068000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495418003486/mslp-20171231.xml#116386 Filing: 000165495418003486 The citation records this snapshot. The page link may show a newer release later.	USD 508,000 Exact value Exact value: 508000 USD 2016-01-01 – 2016-12-31: 508000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2016-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 508000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 508000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495418003486/mslp-20171231.xml#112304 Filing: 000165495418003486 The citation records this snapshot. The page link may show a newer release later.	−USD 15.58 million Calculation and evidence -15068000 − 508000 USD Exact free cash flow: -15576000 USD 2016-01-01 – 2016-12-31: -15068000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 508000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2016-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -15576000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15068000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495418003486/mslp-20171231.xml#116386 Filing: 000165495418003486 Input fundies:CapitalExpenditure: 508000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495418003486/mslp-20171231.xml#112304 Filing: 000165495418003486 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 12.51 million Exact value Exact value: -12509000 USD 2017-01-01 – 2017-12-31: -12509000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2017-12-31 MusclePharm Corp (edgar:1415684) Net Income: -12509000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12509000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#185452 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	−USD 5.13 million Exact value Exact value: -5131000 USD 2017-01-01 – 2017-12-31: -5131000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2017-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -5131000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5131000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#252032 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	USD 37,000 Exact value Exact value: 37000 USD 2017-01-01 – 2017-12-31: 37000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2017-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 37000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#249025 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	−USD 5.17 million Calculation and evidence -5131000 − 37000 USD Exact free cash flow: -5168000 USD 2017-01-01 – 2017-12-31: -5131000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 37000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2017-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -5168000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5131000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#252032 Filing: 000165495420009485 Input fundies:CapitalExpenditure: 37000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#249025 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 10.76 million Exact value Exact value: -10755000 USD 2018-01-01 – 2018-12-31: -10755000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2018-12-31 MusclePharm Corp (edgar:1415684) Net Income: -10755000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10755000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#183455 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	USD 1.98 million Exact value Exact value: 1981000 USD 2018-01-01 – 2018-12-31: 1981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2018-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: 1981000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1981000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#251050 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	USD 132,000 Exact value Exact value: 132000 USD 2018-01-01 – 2018-12-31: 132000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2018-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 132000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 132000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#248210 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.	USD 1.85 million Calculation and evidence 1981000 − 132000 USD Exact free cash flow: 1849000 USD 2018-01-01 – 2018-12-31: 1981000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 132000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2018-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: 1849000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1981000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#251050 Filing: 000165495420009485 Input fundies:CapitalExpenditure: 132000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000165495420009485/mslp-20191231.xml#248210 Filing: 000165495420009485 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 18.93 million Exact value Exact value: -18927000 USD 2019-01-01 – 2019-12-31: -18927000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2019-12-31 MusclePharm Corp (edgar:1415684) Net Income: -18927000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18927000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/mslp-20201231.xml#131847 Filing: 000149315221007088 The citation records this snapshot. The page link may show a newer release later.	−USD 6.52 million Exact value Exact value: -6524000 USD 2019-01-01 – 2019-12-31: -6524000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2019-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -6524000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6524000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/mslp-20201231.xml#170758 Filing: 000149315221007088 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2019-01-01 – 2019-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2019-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/mslp-20201231.xml#170390 Filing: 000149315221007088 The citation records this snapshot. The page link may show a newer release later.	−USD 6.54 million Calculation and evidence -6524000 − 13000 USD Exact free cash flow: -6537000 USD 2019-01-01 – 2019-12-31: -6524000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2019-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -6537000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6524000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/mslp-20201231.xml#170758 Filing: 000149315221007088 Input fundies:CapitalExpenditure: 13000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/mslp-20201231.xml#170390 Filing: 000149315221007088 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 3.19 million Exact value Exact value: 3185000 USD 2020-01-01 – 2020-12-31: 3185000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2020-12-31 MusclePharm Corp (edgar:1415684) Net Income: 3185000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3185000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2019204 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	−USD 868,000 Exact value Exact value: -868000 USD 2020-01-01 – 2020-12-31: -868000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2020-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -868000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501781 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	USD 4,000 Exact value Exact value: 4000 USD 2020-01-01 – 2020-12-31: 4000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2020-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1503249 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	−USD 872,000 Calculation and evidence -868000 − 4000 USD Exact free cash flow: -872000 USD 2020-01-01 – 2020-12-31: -868000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2020-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -872000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501781 Filing: 000149315222017031 Input fundies:CapitalExpenditure: 4000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1503249 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 12.87 million Exact value Exact value: -12866000 USD 2021-01-01 – 2021-12-31: -12866000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Net Income: -12866000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12866000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#2018777 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	−USD 8.04 million Exact value Exact value: -8042000 USD 2021-01-01 – 2021-12-31: -8042000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Operating Cash Flow: -8042000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8042000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501374 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	USD 2,000 Exact value Exact value: 2000 USD 2021-01-01 – 2021-12-31: 2000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Capital Expenditure: 2000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1502923 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.	−USD 8.04 million Calculation and evidence -8042000 − 2000 USD Exact free cash flow: -8044000 USD 2021-01-01 – 2021-12-31: -8042000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MusclePharm Corp · 2021-12-31 MusclePharm Corp (edgar:1415684) Free cash flow: -8044000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1415684?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8042000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1501374 Filing: 000149315222017031 Input fundies:CapitalExpenditure: 2000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1415684/000149315222017031/forms-1.htm#1502923 Filing: 000149315222017031 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

88 filings · 3,357 latest values · 3,357 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001415684, 1415684, MSLP, edgar:1415684, mslp

Also known as MUSCLEPHARM CORP, MusclePharm Corporation, MusclePharm Corp, MusclePharm Corporation, Tone in Twenty

MusclePharm Corp

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation